Clinical Trial Update: Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial of high-dose liposomal amphotericin B for initial treatment of mucormycosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucormycosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Zygomycosis | Phase 2 | Status: COMPLETED